- Home
- LILAK vs BCRX Comparison
LILAK vs BCRX Comparison
Compare LILAK & BCRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LILAK
- BCRX
- Stock Information
- Founded
- LILAK 2017
- BCRX 1986
- Country
- LILAK Bermuda
- BCRX United States
- Employees
- LILAK N/A
- BCRX N/A
- Industry
- LILAK Cable & Other Pay Television Services
- BCRX Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- LILAK Telecommunications
- BCRX Health Care
- Exchange
- LILAK Nasdaq
- BCRX Nasdaq
- Market Cap
- LILAK 1.9B
- BCRX 1.7B
- IPO Year
- LILAK N/A
- BCRX 1994
- Fundamental
- Price
- LILAK $6.97
- BCRX $7.49
- Analyst Decision
- LILAK Buy
- BCRX Strong Buy
- Analyst Count
- LILAK 3
- BCRX 5
- Target Price
- LILAK $11.27
- BCRX $15.60
- AVG Volume (30 Days)
- LILAK 826.3K
- BCRX 2.4M
- Earning Date
- LILAK 11-06-2024
- BCRX 11-04-2024
- Dividend Yield
- LILAK N/A
- BCRX N/A
- EPS Growth
- LILAK N/A
- BCRX N/A
- EPS
- LILAK N/A
- BCRX N/A
- Revenue
- LILAK $4,470,200,000.00
- BCRX $412,579,000.00
- Revenue This Year
- LILAK N/A
- BCRX $37.24
- Revenue Next Year
- LILAK $1.44
- BCRX $19.30
- P/E Ratio
- LILAK N/A
- BCRX N/A
- Revenue Growth
- LILAK N/A
- BCRX 29.92
- 52 Week Low
- LILAK $5.95
- BCRX $4.03
- 52 Week High
- LILAK $10.93
- BCRX $8.88
- Technical
- Relative Strength Index (RSI)
- LILAK 31.09
- BCRX 48.27
- Support Level
- LILAK $6.27
- BCRX $6.92
- Resistance Level
- LILAK $10.67
- BCRX $8.25
- Average True Range (ATR)
- LILAK 0.43
- BCRX 0.46
- MACD
- LILAK -0.13
- BCRX -0.05
- Stochastic Oscillator
- LILAK 15.91
- BCRX 45.71
About LILAK Liberty Latin America Ltd. Class C
Liberty Latin America Ltd is a telecommunications company. It is a provider of video, broadband internet, fixed-line telephony, and mobile services to residential and business customers. The company's reportable segments include C&W Caribbean, Liberty Networks, C&W Panama, VTR, Liberty Puerto Rico, and Liberty Costa Rica. The company generates the majority of its revenue from C&W Caribbean, and Liberty Puerto Rico segments.
About BCRX BioCryst Pharmaceuticals Inc.
BioCryst Pharmaceuticals Inc is a biotechnology company involved mainly in the research and development of novel small-molecule drugs, to block key enzymes involved in infectious and inflammatory diseases. Biocryst's research is based on multiple scientific disciplines like biology, computer modeling, and medicinal chemistry. Its products and candidates target the following therapeutic areas: acute uncomplicated influenza; uncomplicated seasonal influenza; hereditary angioedema; filoviruses, including the Ebola and Marburg viruses; and oncology.